{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:12:40Z","timestamp":1783469560106,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T00:00:00Z","timestamp":1459296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11011-016-9821-2","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T02:45:37Z","timestamp":1459305937000},"page":"881-885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacological evidence of neuro-pharmacological activity of Acacia tortilis leaves in mice"],"prefix":"10.1007","volume":"31","author":[{"given":"Waheeb D. M.","family":"Alharbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Azmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,30]]},"reference":[{"key":"9821_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jep.2007.05.007","volume":"113","author":"OO Adeyemi","year":"2007","unstructured":"Adeyemi OO, Yemitan OK, Olayemi OA (2007) Sedative and anticonvulsant activities of the aqueous root extract Sanseviera liberica Gerome & Labroy (Agavaceae). J Ethnopharmacol 113:111\u2013114","journal-title":"J Ethnopharmacol"},{"key":"9821_CR2","unstructured":"Alharbi WDM, Azmat A (2011). Hypoglycemic and hypocholesterolemic effects of Acacia tortilis (Fabaceae) growing in Makkah. Pak J Pharmacol 28:1\u20138. http:\/\/pakjp.pk\/articles\/24092011084512.pdf"},{"key":"9821_CR3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0074-7742(08)60291-3","volume":"22","author":"SA Barker","year":"1981","unstructured":"Barker SA, Monti JA, Christian ST (1981) N, N-dimethyltryptamine: an endogenous hallucinogen. Int Rev Neurobiol 22:83\u2013110","journal-title":"Int Rev Neurobiol"},{"issue":"11","key":"9821_CR4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","volume":"352","author":"EW Boyer","year":"2005","unstructured":"Boyer EW, Shannon M (2005) \u201cThe serotonin syndrome\u201d (PDF). N Engl J Med 352(11):1112\u20131120","journal-title":"N Engl J Med"},{"key":"9821_CR5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","volume":"13","author":"J Crawley","year":"1980","unstructured":"Crawley J, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167\u2013170","journal-title":"Pharmacol Biochem Behav"},{"key":"9821_CR6","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0006-2952(91)90178-8","volume":"41","author":"AV Deliganis","year":"1991","unstructured":"Deliganis AV, Pierce PA, Perouka SJ (1991) Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors. Biochem Pharmacol 41:1739\u20131744","journal-title":"Biochem Pharmacol"},{"key":"9821_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0021-9673(00)96225-3","volume":"364","author":"L Dimofte","year":"1986","unstructured":"Dimofte L (1986) Identification and determination of N-substituted piperazines by thin-layer and gas chromatography. J Chromatogr 364:353\u2013358","journal-title":"J Chromatogr"},{"key":"9821_CR8","unstructured":"Duke JA (1983) Samanea saman (Jacq.) Merr. Handbook of Energy Crops. unpublished"},{"issue":"1\u20132","key":"9821_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jep.2005.04.004","volume":"100","author":"IS Gary","year":"2005","unstructured":"Gary IS, Anna KJ, Johannes VS (2005) Activity of traditional South African sedative and potentially CNS-acting plants in the GABA-benzodiazepine receptor assay. J Ethnopharmacol 100(1\u20132):210\u2013215. doi: 10.1016\/j.jep.2005.04.004","journal-title":"J Ethnopharmacol"},{"key":"9821_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0376-8716(97)00163-4","volume":"50","author":"B Grella","year":"1998","unstructured":"Grella B, Dukat M, Young R, Teitler M, Herrick-Davis K, Gauthier CB (1998) Investigation of hallucinogenic and related \u03b2-carbolines. Drug Alcohol Depend 50:99\u2013107","journal-title":"Drug Alcohol Depend"},{"key":"9821_CR11","doi-asserted-by":"crossref","unstructured":"Gujar KN, Kasture SB (2005) Involvement of GABA in nootropic and anxiolytic activity of saponins of Albizzia lebbeck leaves ISHS Acta Horticulturae 675: III WOCMAP Congress on Medicinal and Aromatic Plants vol 1: Bioprospecting and Ethnopharmacology vol 1","DOI":"10.17660\/ActaHortic.2005.675.16"},{"key":"9821_CR12","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1176\/appi.ps.53.10.1251","volume":"53","author":"MF Hogan","year":"2002","unstructured":"Hogan MF (2002) Spending too much on mental illness in all the wrong places. Psychiatr Serv 53:1251\u20131252. doi: 10.1176\/appi.ps.53.10.1251","journal-title":"Psychiatr Serv"},{"issue":"3","key":"9821_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0091-3057(03)00128-X","volume":"75","author":"MJ Howes","year":"2003","unstructured":"Howes MJ, Houghton PJ (2003) Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 75(3):513\u2013527. doi: 10.1016\/S0091-3057(03)00128-X","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"9821_CR14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0091-3057(90)90228-A","volume":"35","author":"MP Johnson","year":"1990","unstructured":"Johnson MP, Mathis CA, Shulgin AT, Hoffman AJ, Nichols DE (1990) (125I)-2-(2,5-dimethoxy-4-iodophenyl)aminoethane ((125|)-2-C) as a label for the 5-HT2 receptor in rat frontal cortex. Pharmacol Biochem Behav 35(1):211\u2013217","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"9821_CR15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):593\u2013602","journal-title":"Arch Gen Psychiatry"},{"issue":"14","key":"9821_CR16","first-page":"1690","volume":"6","author":"D Kubmarawa","year":"2007","unstructured":"Kubmarawa D, Ajoku GA, Enwerem NM, Okorie DA (2007) Preliminary phytochemical and antimicrobial screening of 50 medicinal plants from Nigeria. Afr J Biotechnol 6(14):1690\u20131696","journal-title":"Afr J Biotechnol"},{"issue":"2","key":"9821_CR17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pop.2010.02.002","volume":"37","author":"MM Larzelere","year":"2010","unstructured":"Larzelere MM, Campbell JS, Robertson M (2010) Complementary and alternative medicine usage for behavioral health indications. Prim Care 37(2):213\u2013236","journal-title":"Prim Care"},{"issue":"20","key":"9821_CR18","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1021\/jm070714l","volume":"50","author":"JL Maurel","year":"2007","unstructured":"Maurel JL, Autin J-M, Funes P, Newman-Tancredi A, Colpaert F, Vacher B (2007) High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity. J Med Chem 50(20):5024\u20135033","journal-title":"J Med Chem"},{"key":"9821_CR19","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1523\/JNEUROSCI.09-10-03482.1989","volume":"9","author":"DJ McKenna","year":"1989","unstructured":"McKenna DJ, Peroutka SJ (1989) Differentiation of 5-hydroxytryptamine receptor subtypes using 125I-R-(\u2212)2,5-dimethoxyphenylisopropylamine (125I(-R(\u2212)DOI) and 3H-ketanserin. J Neurosci 9:3482\u20133490","journal-title":"J Neurosci"},{"issue":"4","key":"9821_CR20","first-page":"627","volume":"7","author":"PD Meena","year":"2006","unstructured":"Meena PD, Kaushik P, Shukla S, Soni AK, Kumar M, Kumar A (2006) Anticancer and antimutagenic properties of Acacia nilotica (Linn.) on 7,12-dimethylbenz(a)anthracene-induced skin papillomagenesis in Swiss albino mice. Asian Pac J Cancer Prev 7(4):627\u2013632","journal-title":"Asian Pac J Cancer Prev"},{"key":"9821_CR21","unstructured":"Mental Health Atlas (2011) Department of Mental Health and Substance Abuse, World Health Organization. http:\/\/www.who.int\/mental_health\/evidence\/atlas\/profiles\/sau_mh_profile.pdf"},{"issue":"5009","key":"9821_CR22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/bmj.1.5009.8","volume":"1","author":"JNP Moore","year":"1957","unstructured":"Moore JNP, Martin EA (1957) Trial of reserpine in treatment of schizophrenia. Br Med J 1(5009):8\u201314","journal-title":"Br Med J"},{"key":"9821_CR23","unstructured":"National Institute of Health Guidelines for Care and Use of Laboratory Animals in Biomedical Research (2010) Guide for the care and use of laboratory animals. Prepublication draft. 8th edition. The National Academies Press Washington, D.C. 6, 47"},{"key":"9821_CR24","first-page":"81","volume-title":"Ayahuasca analogues: pang\u00e6an entheogens","author":"J Ott","year":"1994","unstructured":"Ott J (1994) Ayahuasca analogues: pang\u00e6an entheogens, 1st edn. Natural Products, Kennewick, pp 81\u201383","edition":"1"},{"key":"9821_CR25","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arc Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arc Int Pharmacodyn Ther"},{"key":"9821_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C (2003) The open field as a paradigm measure the effect of drugs on anxiety-like behaviours: a review. Eur J Pharmacol 463:3\u201333","journal-title":"Eur J Pharmacol"},{"key":"9821_CR27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/np0103620","volume":"65","author":"Y Seo","year":"2002","unstructured":"Seo Y, Hoch J, Abdel-Kader M, Malone S, Derveld I, Adams H, Werkhoven MC, Wisse JH, Mamber SW, Dalton JM, Kingston DG (2002) Kingston bioactive saponins from Acacia tenuifolia from the Suriname rainforest. J Nat Prod 65:170\u2013174","journal-title":"J Nat Prod"},{"key":"9821_CR28","first-page":"247","volume-title":"\u201cDMT is everywhere\u201d. TiHKAL: the continuation","author":"A Shulgin","year":"1997","unstructured":"Shulgin A, Shulgin A (1997) \u201cDMT is everywhere\u201d. TiHKAL: the continuation, 1st edn. Transform Press, Berkeley, pp 247\u2013284","edition":"1"},{"issue":"3\u20134","key":"9821_CR29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0091-3057(01)00516-0","volume":"69","author":"HD Une","year":"2001","unstructured":"Une HD, Sarveiya VP, Pal SC, Kasture VS, Kasture B (2001) Nootropic and anxiolytic activity of saponins of Albizzia lebbeck leaves. Pharmacol Biochem Behav 69(3\u20134):439\u2013444","journal-title":"Pharmacol Biochem Behav"},{"key":"9821_CR30","unstructured":"WHO International Consortium in Psychiatric Epidemiology (2000) Cross-national comparisons of the prevalences and correlates of mental disorders. Bull World Health Organ 78(4)"},{"issue":"4","key":"9821_CR31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.euroneuro.2005.04.012","volume":"15","author":"HU Wittchen","year":"2005","unstructured":"Wittchen HU, Jacobi F (2005) Size and burden of mental disorders in Europe\u2014a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 15(4):357\u2013376","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-016-9821-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-016-9821-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-016-9821-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T02:49:10Z","timestamp":1567738150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-016-9821-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["9821"],"URL":"https:\/\/doi.org\/10.1007\/s11011-016-9821-2","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]}}}